Brain Metastases From Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors

Clinical Genitourinary Cancer - United States
doi 10.1016/j.clgc.2012.11.001
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Elsevier BV

Related search

Concomitant Oral Tyrosine Kinase Inhibitors and Bisphosphonates in Advanced Renal Cell Carcinoma With Bone Metastases

British Journal of Cancer
Cancer ResearchOncology
2012English

Do Tyrosine Kinase Inhibitors Lose Favor in Treatment of First-Line Metastatic Renal Cell Carcinoma?

Future Oncology
MedicineCancer ResearchOncology
2019English

Personalized Therapy in Renal Cell Carcinoma: Are the Different Tyrosine Kinase Inhibitors the Same for Any Patient?

Expert Review of Precision Medicine and Drug Development
Molecular MedicineDrug DiscoveryGeneticsPharmacology
2017English

The Expression and Role of Tyrosine Kinase ETK/BMX in Renal Cell Carcinoma

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Risk Factors for Brain Metastases in Patients With Renal Cell Carcinoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

High Expression of FER Tyrosine Kinase Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2012English

Synchronous Bilateral Adrenal Metastases From Papillary Renal Cell Carcinoma

Journal of Clinical and Analytical Medicine
Medicine
2016English

Stereotactic Radiosurgery for Spinal Metastases From Renal Cell Carcinoma

Journal of Neurosurgery: Spine
MedicineSurgeryNeurology
2005English

Tyrosine Kinase Inhibitors in the Treatment of Choroidal Metastases From Non-Small-Cell Lung Cancer: A Case Report and Review of Literature

Ocular Oncology and Pathology
Nursing
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy